Author(s): Fine EJ, Segal-Isaacson CJ, Feinman RD, Herszkopf S, Romano MC, et al.
Most aggressive cancers demonstrate a positive positron emission tomographic (PET) result using 18F-2-fluoro-2-deoxyglucose (FDG), reflecting a glycolytic phenotype. Inhibiting insulin secretion provides a method, consistent with published mechanisms, for limiting cancer growth.
MethodsEligible patients with advanced incurable cancers had a positive PET result, an Eastern Cooperative Oncology Group performance status of 0 to 2, normal organ function without diabetes or recent weight loss, and a body mass index of at least 20 kg/m2. Insulin inhibition, effected by a supervised carbohydrate dietary restriction (5% of total kilocalories), was monitored for macronutrient intake, body weight, serum electrolytes, β-hydroxybutyrate, insulin, and insulin-like growth factors-1 and -2. An FDG-PET scan was obtained at study entry and exit.
ResultsTen subjects completed 26 to 28 d of the study diet without associated unsafe adverse effects. Mean caloric intake decreased 35 ± 6% versus baseline, and weight decreased by a median of 4% (range 0.0–6.1%). In nine patients with prior rapid disease progression, five with stable disease or partial remission on PET scan after the diet exhibited a three-fold higher dietary ketosis than those with continued progressive disease (n = 4, P = 0.018). Caloric intake (P = 0.65) and weight loss (P = 0.45) did not differ in those with stable disease or partial remission versus progressive disease. Ketosis was associated inversely with serum insulin levels (P = 0.03).
ConclusionPreliminary data demonstrate that an insulin-inhibiting diet is safe and feasible in selected patients with advanced cancer. The extent of ketosis, but not calorie deficit or weight loss, correlated with stable disease or partial remission. Further study is needed to assess insulin inhibition as complementary to standard cytotoxic and endocrine therapies.
Referred From: https://doi.org/10.1016/j.nut.2012.05.001
Author(s): Samaha FF, Iqbal N, Seshadri P, Chicano KL, Daily DA, et al.
Author(s): Yancy WS Jr, Olsen MK, Guyton JR, Bakst RP, Westman EC
Author(s): Wycherley TP, Brinkworth GD, Keogh JB, Noakes M, Buckley JD, et al.
Author(s): Brinkworth GD, Noakes M, Buckley JD, Keogh JB, Clifton PM
Author(s): LaGory EL, Giaccia AJ
Author(s): Klement RJ, Kammerer U
Author(s): Paoli A, Grimaldi K, Toniolo L, Canato M, Bianco A, et al.
Author(s): Westman EC, Yancy WS, Edman JS, Tomlin KF, Perkins CE
Author(s): Freeman JM, Kossoff EH, Hartman AL
Author(s): Noto H, Goto A, Tsujimoto T, Noda M
Author(s): Paoli A, Grimaldi K, D’Agostino D, Cenci l, Moro T, et al
Author(s): Mady MA, Kossoff EH, McGregor AL, Wheless JW, Pyzik PL, et al.
Author(s): Bertoli S, Trentani C, Ferraris C, De Giorgis V, Veggiotti P, et al.
Author(s): Brinkworth GD, Buckley JD, Noakes M, Clifton PM, Wilson CJ
Author(s): Rho JM, Rogawski MA
Author(s): Noh HS, Lee HP, Kim DW, Kang SS, Cho GJ, et al.
Author(s): Astrup A, Meinert Larsen T, Harper A
Author(s): Boden G, Sargrad K, Homko C, Mozzoli M, Stein TP
Author(s): Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, et al.
Author(s): Rolls J
Author(s): Mady MA, Kossoff EH, McGregor AL, Wheless JW, Pyzik PL, et al.